ArticleFrontline gastroenterology2020

Effectiveness of vedolizumab dose intensification to achieve inflammatory bowel disease control in cases of suboptimal response.

Mark A Samaan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.